Sowell Financial Services’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-79
Closed -$6K 1398
2021
Q1
$6K Sell
79
-7
-8% -$645 ﹤0.01% 2527
2020
Q4
$9K Sell
86
-16
-16% -$1.96K ﹤0.01% 2059
2020
Q3
$14K Sell
102
-83
-45% -$13.8K ﹤0.01% 1692
2020
Q2
$36K Sell
185
-352
-66% -$72.9K ﹤0.01% 1275
2020
Q1
$105K Buy
537
+437
+437% +$94K 0.01% 825
2019
Q4
$21K Sell
100
-15
-13% -$2.77K ﹤0.01% 1417
2019
Q3
$18K Buy
+115
New +$18.8K ﹤0.01% 1318

Other funds holding LKFT

Sowell Financial Services's LKFT Position: Q2 2021 in Review

Sowell Financial Services sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 79 shares — an estimated $6K sold.

Sowell Financial Services first reported a position in LKFT in Q3 2019 and held it in 7 quarters. The position peaked at $105K in Q1 2020. 109 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

  • Sowell Financial Services reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 79 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $6K.
  • Sowell Financial Services first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Lakefront Biotherapeutics American Depositary Shares position peaked at $105K in Q1 2020.
  • 109 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.